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cal (PCS-12). The SF-12 scores of the parents, for all dermatoses
together, on arrival (n = 400) were: PCS-12 = 46.9 & MCS-
12 = 39.4. The improvement in the parents’ quality of life in the
mental dimension is statistically signiﬁcant (MCS-12 = 39.4 to
40.7). CONCLUSIONS: This study shows an alteration in the
quality of life of parents whose children suffer from chronic
dermatoses. The overall treatment at the hydrotherapy center
improves quality of life—in its mental dimension—of the
parents. Our study conﬁrms the pertinence of using thermal
therapy, but also for the ﬁrst time demonstrates sustained
improvement in quality of life at 3 months and perpetuation at 6
months for children under 15.
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HOSPITAL DERMATOLOGY CONSULTATIONTYPES:
A FRENCH ASSESSMENT
Bousetta S,Taieb C
Pierre Fabre, Boulogne, France
OBJECTIVES: To evaluate the skin diseases most frequently
treated in the outpatient clinics of the dermatology departments
in 5 university teaching hospitals located throughout France
(Besançon, Brest, Lyons, Paris and St Etienne). METHODS: For
5 consecutive days, ﬁve dermatology departments assessed the
types of skin diseases seen in the outpatient clinic. RESULTS: 658
adult patients agreed to take part in the assessment. The derma-
tologist alone or with the help of the patient completed the
individual questionnaires. Mean patient age was 48.9  19.3
years. The 4 major dermatoses for which patients consulted were
melanotic tumours, atopic dermatitis, psoriasis and acne (18.1%,
10.6%, 10.2% and 5.4% of consultations respectively). Atopic
dermatitis, psoriasis and acne accounted for more than one
quarter of appointments (26.2%). Atopic dermatitis and acne
were the two primary reasons for consultation in the under 35 s,
accounting for respectively 20.9 and 14.7% while in the over 35
age group, melanotic tumours and psoriasis were the two major
motives (21.3% and 10.2%, respectively). For all these derma-
toses, the sex ratio was in favour of women (from 54 to 69%)
with the exception of psoriasis, for which the sex ratio was, on
the contrary, in biased towards men. In total, 39.1% of respond-
ers consulted their dermatologist when their skin condition
worsened. The self-perceived stress level showed a statistically
signiﬁcant difference depending on the skin condition for which
the appointment was made (11.4, 10.4, 9.2 and 8.9 for psoriasis,
acne, atopic dermatitis and melanotic tumours). CONCLU-
SIONS: This assessment shows that patients of all ages visit
hospital dermatology outpatient clinics. The diversity of the skin
conditions treated at these clinics bears witness to the accessibil-
ity of appointments and is a clear indication of the need for these
hospital clinics in addition to the dermatological care available in
the community.
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OBJECTIVES: To develop a disease model based on the litera-
ture ﬁndings, illustrating the impact of psoriasis on patients’
lives. METHODS: Biomedical databases were searched using
keywords related to psoriasis and social, psychological, and
physical impacts. Articles containing concepts related to psoria-
sis and important to patients were retained. Relevant concepts
were extracted, put into homogenous groups and organised in a
diagram according to Wilson and Cleary’s model. Finally, sta-
tistically signiﬁcant links between concepts were reported in the
diagram. RESULTS: Among 374 abstracts reviewed, 35 articles
were selected for the construction of the model. The concepts
identiﬁed in publications were extracted and put into 5 groups:
disease-related characteristics (risk factors, signs and symptoms,
biological, functional, psychological status); environment (social
life, medical, emotional, other people); individual characteristics
(socio-demographics, co-morbidities, beliefs, personality, coping
strategies); treatment; and overall quality of life. Disease char-
acteristics (especially signs and symptoms), appeared to be very
important to patients, and was the concept most widely corre-
lated with others. Psychological status, including psychological
distress, also emerged as an essential concept for patients with
psoriasis, and was related to coping strategies such as avoid-
ance. Functional status and social life seemed to be impaired,
resulting in restrictions in activities of daily living, sexual rela-
tionships, or work, leading to social withdrawal. Finally, the
role of stress appeared to be complex, as it can be a risk factor,
a personality trait, or a consequence of psoriasis. CONCLU-
SIONS: This model illustrates the impact of psoriasis on many
domains of patients’ lives. It highlights the successive conse-
quences leading from symptoms to health-related quality of life.
It also shows the amount of available evidence, allowing ele-
ments that require further exploration to be identiﬁed. Finally,
the model describes the interactions between individual and
environmental factors, as well as the complexity of some factors
(e.g. stress).
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OBJECTIVES: Chronic Urticaria (CU) is a frequent dermatology
disease that has a great impact on Health-Related Quality of Life
(HRQoL). Nowadays there is no HRQoL speciﬁc questionnaire
in CU in spanish population. The objective is to develop the
URQoL questionnaire in Spanish patients with CU. METHODS:
In order to deﬁne the main dimensions the questionnaire should
cover, a literature review and a focus group with 4 dermatologist
were performed. Additionally a semi-structured interview was
conducted in 11 patients with CU to evaluate the impact of the
disease, symptoms and treatment on HRQoL. From the content
of the interviews a ﬁrst pool of items were identiﬁed. Each item
was subsequently rated by the dermatologist, according to
clarity, frequency and importance to reduce the number of items.
Remaining items were edited in a questionnaire format and
administered to a sample of patients. A debrieﬁng analysis and
preliminary psychometric analysis were performed to obtain the
ﬁnal pilot questionnaire before the validation study. RESULTS: A
total of 33 patients were enrolled in the pilot study. Mean (SD)
age 48.1(14.7) year, 66.7% were woman. After qualitative reduc-
tion a 21 items questionnaire was obtained (URQoL). One of the
items was reformulated and the answer option ‘not applicable’
was added in two items (one related to working activity and the
other one related to sexual activity). CONCLUSIONS: URQoL
is a new HRQoL questionnaire with good initial measurement
properties. With the data obtained in the ongoing validation
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study, a Rasch analysis will be performed and the validation
process will be completed with the remaining measurement prop-
erties (feasibility, validity, reliability and responsiveness to
change) and with a higher number of patients.
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OBJECTIVES: To reduce, score and assess the psychometric
properties of the Freedom from Glasses Value Scale (FGVS), a
new scale developed to measure beneﬁts of freedom from
glasses in cataract and presbyopic patients after multifocal
intraocular lens (IOL) surgery. METHODS: The FGVS, a
21-item Patient-Reported Outcomes instrument, was developed
simultaneously in French and Spanish. It was administered by
phone in a study conducted with 152 French and 152 Spanish
patients who underwent cataract or presbyopia surgery at least
1 year before the interview. Statistical methods (principal com-
ponent analysis, multi-trait analysis) and content analysis were
used to select the items and to score the FGVS. Psychometric
properties (validation of the structure, internal consistency reli-
ability, known-group validity) of the resulting version were
assessed in the pooled population and by country. RESULTS:
One item was removed from the FGVS, three motivation items
were kept but not aggregated in a dimension, and two main
dimensions were deﬁned (‘global evaluation’, 9 items; ‘advan-
tages’, 8 items). These two dimensions contain ﬁve subscores
(‘evaluation of the results’, 2 items; ‘feelings’, 4 items; ‘global
judgment’, 3 items; ‘psychological advantages’, 3 items; ‘prac-
tical advantages’, 5 items). A higher score indicates a higher
beneﬁt from surgery. The scores presented good psychometric
properties; all items met the convergent validity criterion and
only three did not meet the discriminant validity criterion.
Cronbach’s alpha was greater than 0.70 for all dimensions and
sub-dimensions (good internal consistency reliability), and the
FGVS was able to discriminate between patients wearing glasses
or not after surgery (higher scores for patients not wearing
glasses). FGVS scores were signiﬁcantly higher in Spain than in
France, however, they showed similar psychometric perfor-
mances in both countries. CONCLUSIONS: The FGVS is a
valid and reliable instrument measuring beneﬁts of freedom
from glasses perceived by cataract and presbyopic patients after
multifocal IOL surgery.
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OBJECTIVES: To ascertain the scoring and to assess the psycho-
metric properties of the Eye-Drop Satisfaction Questionnaire
(EDSQ). METHODS: The EDSQ was developed to assess the
satisfaction and compliance of patients with glaucoma treatment.
The hypothesised model content of the questionnaire resulting
from patient and clinician interviews organised 43 items into
six domains: Patients characteristics, Treatment characteristics,
Patient-clinician relationship, Patient experience, Patient-
treatment interaction, and Patient knowledge. The EDSQ was
included in a observational, multicenter study in France in
patients treated for glaucoma. The scoring of the EDSQ was
investigated by testing several possible structures, resulting from
the hypothesised model/Factor Analysis. Psychometric properties
of the retained structure were assessed: internal consistency reli-
ability (Cronbach’s alpha) and construct validity (multitrait
analysis). Distributional features (missing data, ceiling and ﬂoor
effects) of the EDSQ scores were scrutinised. RESULTS: Analyses
were performed with 169 patients who had completed more than
half of the EDSQ items. The retained structure, resulting from
Principal Component Analysis, included six domains: Concern
about treatment (5 items), Concern about disease (2 items),
Satisfaction with patient-clinician relationship (5 items), Positive
beliefs (3 items), Treatment convenience (3 items), and Declared
compliance (3 items). Items not included in the domains were
kept for separate analysis. Cronbach’s alpha of the domains was
greater than 0.7 for ﬁve domains and ranged from 0.65 to 0.90.
The structure offered good item convergent and item divergent
validity (range of item-scale correlation: 0.36–0.82). Moderate
ceiling effect was observed for the Satisfaction with patient-
clinician relationship score (20% at maximum score), reﬂecting
good relationships. An important ceiling effect was also observed
for the Declared compliance score, with patients declaring high
levels of compliance (49% at maximum score). CONCLU-
SIONS: The scoring of the EDSQ was developed and the ques-
tionnaire was shown to have satisfactory psychometric
properties.
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OBJECTIVES: To assess the parents’/caregivers’ behavior of the
pediatric patient with atopic dermatitis (AD) stratiﬁed by type,
severity and ﬂare-up area. METHODS: An epidemiological,
cross-sectional study in patients 2–12 years old with mild or
moderate AD and at least two ﬂares in the previous year, were
conducted in 451 paediatric sites. Patient characteristics and a
brief clinical history were asked to caregivers. Data about the
management and characteristics of ﬂares were requested to car-
egivers. The satisfaction with treatment use was also requested.
A logistic regression was performed to analyze the predictive
factors of worries to use corticosteroids. Moreover, the odds
ratio (OR) of them were calculated. RESULTS: A total of 1177
patients were included. A total of 52.3% boys with a mean
(SD) of 5.3(2.8) years old. A total of 66.4% of patients had
family history of AD, two third of them were parents. The
mean (SD) age at diagnosis was 1.6 (1.5). The lesions are
mainly presented in upper and lower extremities and face/neck
(>70%). The parents’/caregivers’ visits to the doctor was six
times greater for moderate episodes vs mild ones (OR = 6.15,
IC95%: 5.12–7.14; p < 0.0001). Regarding visits according to
age, there were an 8% visits decrease for each year of age
(OR = 0.92, IC95%: 0.89–0.96; p < 0.0001). A total of 19.3%
of caregivers never use corticosteroids in lesions on face/neck,
and 52.4% could use it only as an alternative option. However,
when lesions are presented in other parts of body, 48.9% of
caregivers use it as ﬁrst line option. The most commonly used
treatments are moisturizing products (31.0%), topical immuno-
modulators (30.3%) and strong corticosteroids (23.3%). There
are three predictive factors related to avoid use of corticoster-
oids: location in face/neck (OR = 4.47, IC95%: 3.50–5.72),
mild severity (OR = 1.98, IC95%: 1.48–2.66) and low age
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